A Randomized Clinical Trial on the Effects of Progestin-based Contraception in the Genital Tract of HIV-infected and Uninfected Women
Phase of Trial: Phase IV
Latest Information Update: 30 Jul 2019
Price : $35 *
At a glance
- Drugs Levonorgestrel (Primary) ; Medroxyprogesterone
- Indications Pregnancy
- Focus Adverse reactions
- 30 Jul 2019 Results of the secondary analysis, published in the Contraception
- 15 Mar 2018 Status changed from active, no longer recruiting to completed.
- 29 Sep 2015 Planned End Date changed from 1 Sep 2015 to 1 Oct 2017 as reported by ClinicalTrials.gov record.